The Evaluation of the Effectiveness of CAM Treatments for Lumbar and Cervical Spine Pain Patients Due to Spinal Disease

Overview

The purpose of this study is to investigate the effect of CAM treatments consisting of herbal medicine, Chuna manual therapy, pharmacoacupuncture, acupuncture on lumbar and cervical spine pain patients due to spinal disease.

Full Title of Study: “The Evaluation of the Effectiveness of CAM Treatments for Lumbar and Cervical Spine Pain Patients Due to Spinal Disease : Prospective, Observational Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: September 2013

Detailed Description

"The purpose of this study is to investigate the effect of CAM treatments on lumbar and cervical spine pain patients due to spinal disease. After subjects selected by screening, who receive CAM treatments 1-2times a week for more than 2 months and F/U at 1st, 2nd, 3rd month by meeting and F/U at 6nd, 12nd month by calling. The CAM treatments used in this study consists of 120ml of Chuna herbal medicine(Ostericum koreanum, Eucommia ulmoides, Acanthopanax Sessiliflorus, Achyranthes bidentata, Psoralea corylifolia, Peucedanum japonicum, Cibotium barometz, Lycium chinense, Boschniakia rossica, and Cuscuta chinensis) and dried extracts in pill form(Cibotium barometz, Atractylodes japonica) taken twice a day 30 minutes after meals, Chuna manual therapy, intermuscular injections of bee-venom pharmacoacupuncture(Select 6 acupoints, concentration 10,000:1, 0.1 cc per acupoint, total amount injected 1.0 cc/session), acupuncture and allow for NSAID intake during the investigational period. The subject is allowed a maximum of 3 pills/day, taken at a minimum of 8 hrs apart. The number of pills taken will be measured at 4 wks after conclusion of treatment."

Interventions

  • Drug: herbal medicine
    • 120ml of Chuna herbal medicine(Ostericum koreanum, Eucommia ulmoides, Acanthopanax Sessiliflorus, Achyranthes bidentata, Psoralea corylifolia, Peucedanum japonicum, Cibotium barometz, Lycium chinense, Boschniakia rossica, and Cuscuta chinensis) taken twice a day 30 minutes after meals for more than 2 months
  • Procedure: Chuna manual therapy
    • A type of Korean spinal manual therapy administered 5~10 minutes at physician’s discretion 1-2times a week for more than 2 months Applies mobilization using High-Velocity, Low-Amplitude thrusts to joints slightly beyond the passive ROM and manual force within the passive ROM without thrusts.
  • Procedure: Acupuncture
    • Acupuncture using sterilized disposable needles, sized 0.30X40mm. Needles left for 15~20 minutes, selecting 6 acupoints(both BL23, BL24, BL25 ) and other acupoints at physician’s discretion, using a total of 10~20 acupoints 1-2times a week for more than 2 months
  • Procedure: Bee-venom pharmacoacupuncture/pharmacoacupuncture
    • pharmacoacupuncture using 30G sterilized bee venom. Selecting 6 acupoints(both BL23, BL24, BL25) and other acupoints at physician’s discretion, concentration 10,000:1, 0.1 cc per acupoint, total amount injected 1.0 cc/session 1-2times a week for more than 2 months

Arms, Groups and Cohorts

  • CAM treatment

Clinical Trial Outcome Measures

Primary Measures

  • NRS of low back pain or neck pain/NRS of radiating pain
    • Time Frame: Change from Baseline at 3rd month

Secondary Measures

  • ODI (Oswestry Disability Index)
    • Time Frame: Baseline, 1st month, 2nd month, 3rd month
  • Patient satisfaction
    • Time Frame: 3rd month
    • Patient satisfaction of treatment
  • Job loss
    • Time Frame: Baseline, 1st month, 2nd month, 3rd month
    • Life activity of loss rate
  • painkiller intaken of times
    • Time Frame: Baseline, 3rd month
  • Adverse reactions
    • Time Frame: Baseline, 1st month, 2nd month, 3rd month

Participating in This Clinical Trial

Inclusion Criteria

  • Patients suffering from low back pain or Neck due to spinal disease Agree to the treatment of more than 2 months – Age all(If under 18yr, Guardian's consent need) – Volunteers do not have a problem with my speech as those who have signed the consent Exclusion Criteria:

  • Diagnosis of serious disease(s) which are possible causes of back pain such as malignancy, vertebral fracture, spinal infection, inflammatory spondylitis, cauda equina compression, etc. – Prior diagnosis of other chronic disease(s) which could affect effectiveness or interpretation of treatment results such as cardiovascular disease, diabetic neuropathy, fibromyalgia, rheumatoid arthritis, Alzheimer's disease, epilepsy, etc. – Progressive neurologic deficit(s) or concurrent severe neurological symptoms Unsuitable for or at risk of complications from acupuncture treatment such as patients with clotting disorders, severe diabetes with risk of infection, serious cardiovascular disease, or undergoing anticoagulant treatment, etc. – Under prescription of corticosteroids, immuno-suppressant drugs, psychiatric medicine, or other medication considered unsuitable for subjects by the researcher – Experience of gastroenteric complications after taking NSAIDs or currently undergoing treatment for digestive disorders – During pregnancy or suspected pregnancy – Subjects considered unsuitable for clinical trial by the researcher

Gender Eligibility: All

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Jaseng Hospital of Korean Medicine
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Jinho LEE, KMD, Principal Investigator, Jaseng Hospital of Korean Medicine

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.